High Mpox Vaccine Price to Pose Key Hurdle in Africa Order Talks

The price of Bavarian Nordic A/S’s mpox vaccine is set to become a key sticking point in talks to secure millions of shots for Africa, with the Danish company under growing pressure to lower its charge.

As the first batch of more than 200,000 doses arrive in the Democratic Republic of the Congo, talks led by agencies including Unicef are underway to secure more vaccines for crisis-hit African countries. Initial agreements are slated to be finalized by mid-September.